Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

For Industry

Webinar: Background on FDA and Patient-Focused Drug Development

Patient-Focused Drug Development is an initiative that involves obtaining a better understanding of patients’ perspectives on the severity of their disease and the available therapies for their condition. Patient-Focused Drug Development is being conducted to fulfill FDA performance commitments made as part of the authorization of the Prescription Drug User Fee Act under Title I of the Food and Drug Safety and Innovation Act (FDASIA) (Pub. L. 112–144).

The purpose of this webinar is to provide patient stakeholders with a background on the meetings under the Patient-Focused Drug Development initiative. This webinar is split into four modules, each focusing on a separate topic.

Webinar Modules

Page Last Updated: 05/05/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English